lipotecan
Small moleculeexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00747474)
Timeline
Indications
Mechanism of action
- Topoisomerase IINHIBITOR
Topoisomerase I inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lipotecan
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03035006 | Phase 1/Phase 2 (Phase 2) | Apr 14, 2017 | National Taiwan University, Taiwan Liposome Company |
| NCT02267213 | Phase 2 | Mar 1, 2014 | IQVIA, National Taiwan University, Taiwan Liposome Company |
| NCT01831973 | Phase 2 | Oct 1, 2012 | Taiwan Liposome Company |
| NCT01425996 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2011 | Far Eastern Memorial Hospital, Mackay Medical College, National Yang-Ming University, Taipei Medical University, Taiwan Liposome Company |
| NCT00747474 | Phase 1 | Sep 1, 2008 | Taiwan Liposome Company |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Taiwan Liposome Company | For profit | 5 | 5 | 2 | 2008 |
| National Taiwan University | Academic/Hospital | 2 | 0 | 1 | 2014 |
| Far Eastern Memorial Hospital | Academic/Hospital | 1 | 0 | 1 | 2011 |
| IQVIA | For profit | 1 | 0 | 1 | 2014 |
| Mackay Medical College | Academic/Hospital | 1 | 0 | 1 | 2011 |
| National Yang-Ming University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Taipei Medical University | Academic/Hospital | 1 | 0 | 1 | 2011 |
7 organizations
Page 1 / 1